Advertisement
Screener

Atrium Therapeutics, Inc. (RNA) Net Margin

Atrium Therapeutics, Inc. Net Margin

Net margin is the percentage of revenue a company keeps as profit after every expense and tax. It is net income divided by revenue, and the table shows both amounts beside the percentage. A higher net margin means more of each sales dollar reaches the bottom line. One-time gains, write-downs and tax items pass through net income, so a single period's net margin can move for reasons unrelated to the underlying business. Quarterly and annual points each use the amounts filed for that same period, so a single quarter can swing with the seasons.

  • Atrium Therapeutics, Inc. net margin for the quarter ending 2026-06-30 was -671.97%, a change of -337.19% year-over-year.
  • Atrium Therapeutics, Inc. net margin for the quarter ending 2026-03-31 was -84.71%, a change of 388.84% year-over-year.
  • Atrium Therapeutics, Inc. net margin for the quarter ending 2025-06-30 was -334.78%.
  • Atrium Therapeutics, Inc. net margin for the quarter ending 2025-03-31 was -473.55%.
Available history
2025-03-31 to 2026-06-30
Data captured

Historical Net Margin

DateNet MarginNet incomeRevenue
2026-06-30-671.97%-$20.19M$3M
2026-03-31-84.71%-$16.63M$19.64M
2025-06-30-334.78%-$12.88M$3.85M
2025-03-31-473.55%-$7.45M$1.57M

Annual Net Margin

DateNet MarginNet incomeRevenue

Similar stocks

Stock NameCountryMarket CapPE Ratio
Korro Bio, Inc. (KRRO)United States$0.141B-1.81
SPRUCE BIOSCIENCES, INC. (SPRB)United States$0.142B-2.89
Curanex Pharmaceuticals Inc (CURX)United States$0.138B
Corbus Pharmaceuticals Holdings, Inc. (CRBP)United States$0.144B-1.72
TuHURA Biosciences, Inc./NV (HURA)United States$0.134B-4.88
Unicycive Therapeutics, Inc. (UNCY)United States$0.134B-3.70
Annexon, Inc. (ANNX)United States$0.147B-4.22
NRX Pharmaceuticals, Inc. (NRXP)United States$0.131B-6.31
MEDICINOVA INC (MNOV)United States$0.130B-6.04
IMMUNIC, INC. (IMUX)United States$0.127B-1.88